These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8765364)

  • 1. [Dynamic MR mammography: is the course of signal intensification suitable for the differentiation of different forms of mastopathy?].
    Sittek H; Kessler M; Heuck AF; Lebeau A; Kohnert M; Untch M; Bohmert H; Reiser M
    Rofo; 1996 Jul; 165(1):59-63. PubMed ID: 8765364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MR mammography in patients at risk].
    Kaiser WA; Mittelmeier O
    Rofo; 1992 Jun; 156(6):576-81. PubMed ID: 1617179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
    Gökalp G; Topal U
    Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
    Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
    Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamic imaging with magnetic resonance in the diagnosis of breast disease].
    Ercolani P; Giovagnoni A; Giuseppetti G; Baldassarre S; De Nigris E; Amici F
    Radiol Med; 1991 Oct; 82(4):422-6. PubMed ID: 1767046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].
    Kuhl CK; Kreft BP; Hauswirth A; Gieseke J; Elevelt A; Reiser M; Schild HH
    Rofo; 1995 Jun; 162(6):482-91. PubMed ID: 7605960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
    Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
    Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The nipple in MR mammography--the normal findings and the signs of disease].
    Ohmenhäuser K; Müller-Schimpfle M; Claussen CD
    Rofo; 1999 Jul; 171(1):20-5. PubMed ID: 10464500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamic 3D MR mammography using a rapid gradient-echo sequence].
    Müller-Schimpfle M; Rieber A; Kurz S; Stern W; Claussen CD
    Rofo; 1995 Jan; 162(1):13-9. PubMed ID: 7841394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI in insulin-dependent diabetic mastopathy. A case report.
    Costantini M; Belli P; Magistrelli A; Romani M; Pastore G
    Rays; 2002; 27(4):307-12. PubMed ID: 12696293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery.
    Boné B; Aspelin P; Isberg B; Perbeck L; Veress B
    Acta Radiol; 1995 Mar; 36(2):111-6. PubMed ID: 7710787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative assessment of therapy related effects after breast conserving therapy with dynamic MRI of the breast].
    Wersebe A; Xydeas T; Clauss T; Dietz K; Belka C; Fersis N; Claussen CD; Müller-Schimpfle M
    Rofo; 2001 Dec; 173(12):1109-17. PubMed ID: 11740672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
    Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.
    Barile A; Sabatini M; Iannessi F; Di Cesare E; Splendiani A; Calvisi V; Masciocchi C
    Radiol Med; 2004 Apr; 107(4):356-66. PubMed ID: 15103287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of MR-mammography at 1.5 tesla in the differential diagnosis of non-puerperal mastitis and inflammatory breast carcinoma].
    Tomczak R; Rieber A; Zeitler H; Rilinger N; Kreienberg R; Brambs HJ
    Rofo; 1996 Aug; 165(2):148-51. PubMed ID: 8924667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences].
    Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R
    Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced dynamic MR imaging parameters and histological types of invasive ductal carcinoma of breast.
    Takeda Y; Yoshikawa K
    Biomed Pharmacother; 2005 Apr; 59(3):115-21. PubMed ID: 15795104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contrast medium assisted dynamic MR-mammography after diagnostic and therapeutic interventions on the breast].
    Fischer U; Vosshenrich R; Kopka L; Kahlen O; Grabbe E
    Bildgebung; 1996 Jun; 63(2):94-100. PubMed ID: 8756151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T].
    Fischer U; Westerhof JP; Brinck U; Korabiowska M; Schauer A; Grabbe E
    Rofo; 1996 Apr; 164(4):290-4. PubMed ID: 8645861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.